Noah Wald-Dickler, MD

Clinical Assistant Professor of Population and Public Health Sciences

Image of Noah Wald-Dickler, MD
Is this your profile? Click to edit

Overview

Dr. Wald-Dickler is an Assistant Professor of Medicine and of Population and Public Health Sciences and a lecturer in the USC Keck School of Medicine’s Master of Science (MSc) in Global Medicine Program. Dr. Wald-Dickler is also Chief of the Division of Infectious Diseases at Los Angeles General Medical Center where he also serves as Hospital Epidemiologist and Medical Director of Infection Prevention & Control.

He is active clinical faculty in the Department of Medicine and Division of Infectious Diseases at the Los Angeles General Medical Center, where he also serves as Chair of the Pharmacy & Therapeutics Committee and its Antimicrobial Subcommittee. He is the physician director of LA General’s Antimicrobial Stewardship Program.

In addition to previous work in HIV clinical trials, Dr. Wald-Dickler’s research interests are varied and include Hospital Epidemiology and practical implementation of Antimicrobial Stewardship with an emphasis on safe transition from IV to oral antibiotics.

Awards

  • American College of Physicians: Fellow Status, 2022
  • University of Southern California: Resident Teacher of the Year, 2016
  • University of Southern California: Junior Resident of the Year, 2015
  • University of Southern California: Intern of the Year, 2014
  • University of Missouri: Book Award for Student Excellence in Medicine, 2013
  • Arizona State University Barrett Honors College: Magna Cum Laude Graduate, 2008

Education and Training

  • LAC+USC Medical Center, Los Angeles — 06/2018 — Infectious Disease Fellowship
  • LAC+USC Medical Center, Los Angeles — 06/2016 — Internal Medicine Residency
  • University of Missouri – Columbia, Columbia, MO — MD — 06/2013 — Medical School

Publications

  • Effect of different management strategies on outcomes in subarachnoid neurocysticercosis: a descriptive, multicentre, retrospective cohort study in the USA. EClinicalMedicine. 2026 Apr; 94:103861.. View in PubMed
  • Thrombotic Thrombocytopenic Purpura in a Patient With Triple-Negative Breast Cancer Treated With PD-L1 Inhibition and Taxane Chemotherapy. Clin Case Rep. 2026 Mar; 14(3):e72247.. View in PubMed
  • Single-Dose Liposomal Amphotericin Plus Fluconazole and Flucytosine for Cryptococcal Meningitis at a US Public Hospital. JAMA Netw Open. 2026 Jan 02; 9(1):e2553552.. View in PubMed
  • 2025 Update to WikiGuidelines for the management of pyogenic osteomyelitis in adults. Am J Med. 2026 Apr; 139(4):395-398.. View in PubMed
  • Reply to Datta, “Is static or cidal antibiotic falsifiable?” Antimicrob Agents Chemother. 2025 Nov 05; 69(11):e0139125. Spellberg B, Wald-Dickler N , Holtom P, Meyer-Sautter P, Camp A, Diaz AD, Buhama . View in PubMed
  • Practicing With Intent: How to Teach an Old Dogma New Tricks. Clin Infect Dis. 2025 10 06; 81(3):410-413.. View in PubMed
  • Static vs. cidal: it’s not complex; it’s simply incorrect. Antimicrob Agents Chemother. 2025 Aug 06; 69(8):e0051325.. View in PubMed
  • Shaping the Future of Infectious Diseases: The Journey to Promote Value, Opportunity, and Positive Messaging. Open Forum Infect Dis. 2024 Dec; 11(12):ofae669.. View in PubMed
  • Revisiting diagnostics: erythrocyte sedimentation rate and C-reactive protein: it is time to stop the zombie tests. Clin Microbiol Infect. 2025 Jan; 31(1):1-4.. View in PubMed
  • Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19. Clin Infect Dis. 2024 06 14; 78(6):1490-1503.. View in PubMed